Related Experiment Video
Updated: Jun 20, 2026

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Screening for sarcopenia risk using SARC-F and its relationship with laboratory parameters in primary care
İsmail Çifçi1, Bilal Durmaz2, Esra Meltem Koç3
1Karabaglar 27th Family Health Center, Turkish Ministry of Health, Izmir, Turkiye.
Background/Aim:
Sarcopenia screening in primary care is limited by time and workload. The aim of this study was to investigate the relationship between SARC-F (Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls)-defined sarcopenia risk and routine laboratory parameters in primary care. Additionally, the study aimed to determine the prevalence of sarcopenia risk, as defined by the SARC-F, in the study population.
Materials And Methods:
Data were collected from individuals aged 65 and older (n = 396) registered at two family health centers in İzmir who had complete SARC-F and laboratory data. Sarcopenia risk was defined as a SARC-F score of 4 or higher. Demographic, clinical, and routine laboratory data were obtained from electronic records. Multivariate logistic regression, Pearson chi-square test, and Mann-Whitney U test were used for statistical analysis. A p-value <0.05 was considered statistically significant.
Results:
The study included 396 individuals with an average age of 70 ± 6.3 years, of whom 55.1% were female. Sarcopenia risk was present in 16.9% of participants (20.6% in women and 12.3% in men). Multiple logistic regression analyses showed that increased age (OR = 1.250, 95% CI = 1.177-1.327), female sex (OR = 2.284, 95% CI = 1.057-4.934), higher BMI (body mass index) (OR = 1.106, 95% Cl = 1.026-1.193), lower ferritin (OR = 0.992, 95% Cl = 0.985-1.000), and lower albumin (OR = 0.777, 95% Cl = 0.693-0.871) levels were associated with an increased risk of sarcopenia.
Conclusion:
The results of our study indicate that the risk of sarcopenia can be quite a common clinical condition in primary care. When increased clinical demands and limited time hinder the use of tests such as SARC-F, routine laboratory tests may help identify individuals at risk of sarcopenia.